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Purpose. To examine the influence of positional misalignments on intraocular pressure (IOP) measurement with a rebound
tonometer. Methods. Using the iCare rebound tonometer, IOP readings were taken from the right eye of 36 healthy subjects at
the central corneal apex (CC) and compared to IOPmeasures using the Goldmann applanation tonometer (GAT). Using a bespoke
rig, iCare IOP readings were also taken 2mm laterally fromCC, both nasally and temporally, along with angular deviations of 5 and
10 degrees, both nasally and temporally to the visual axis. Results. Mean IOP± SD, asmeasured by GAT, was 14.7±2.5mmHg versus
iCare tonometer readings of 17.4 ± 3.6mmHg at CC, representing an iCare IOP overestimation of 2.7 ± 2.8mmHg (𝑃 < 0.001),
which increased at higher average IOPs. IOP at CC using the iCare tonometer was not significantly different to values at lateral
displacements. IOP was marginally underestimated with angular deviation of the probe but only reaching significance at 10 degrees
nasally. Conclusions. As shown previously, the iCare tonometer overestimates IOP compared to GAT. However, IOP measurement
in normal, healthy subjects using the iCare rebound tonometer appears insensitive to misalignments. An IOP underestimation of
<1mmHg with the probe deviated 10 degrees nasally reached statistical but not clinical significance levels.
1. Introduction
The iCare TA01i (Icare Finland Oy, Helsinki, Finland)
rebound tonometer is a relatively recent addition to the
portfolio of tonometers currently available to the ophthalmic
practitioner for measuring intraocular pressure (IOP). Hith-
erto, studies have shown that the rebound tonometer per-
forms adequately as a screening tool in comparison to the
Goldmann applanation tonometer (GAT; Clement Clarke
International, Harlow, UK) and other handheld tonometry
devices [1–4].
In brief, the iCare TA01i rebound tonometer comprises
a solenoid and housing, a magnetised probe, and other
associated electronics. The probe is 40mm long, 0.3mm
in diameter with a 1.7mm diameter plastic end-tip [5].
The device employs a solenoid to fire the probe to travel
towards the cornea at a velocity of approximately 0.2m/s.
Following the propulsion pulse, electronics switch tomonitor
the voltage induced in the solenoid coil by the movement
of the magnetised probe, allowing the speed and direction
of probe movement to be monitored. Signal processing
electronics andmicrocontrollers then derive the probe decel-
eration time on corneal impact and convert this to a measure
of IOP.
As the iCare probe has a small footprint, it is possible
to measure IOP in a number of corneal positions; this
is particularly useful in the presence of central corneal
abnormalities. What remains equivocal, however, is the
impact of probe-cornea misalignments on the resultant IOP
reading. Previous studies have attempted to elucidate these
putative erroneous errors; however, to date, these studies have
generally neglected to examine the central 4mmcorneal zone
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within which most readings would normally be acquired,
clinically. Instead, studies have measured IOP at positions
2mm from the limbus [6–8]. Further, the exact methods
adopted to adjust probe position in relation to the cornea are
often an approximation using rudimentary techniques [9, 10]
and they generally lack any real quantifiable level of precision
and accuracy [11].
The aim of the present study, therefore, was to assess the
impact of iCare TA01i probe-cornea misalignments on IOP
using a bespoke alignment rig with a high level of positional
accuracy and precision. Here, measurements were acquired
with horizontal angular deviations at 5∘ and 10∘, both nasally
and temporally. Further, in contrast to previous research,
lateral misalignments were assessed within the central 4mm
corneal zone.
2. Methods
Data were collected from the right eyes of 36 healthy subjects
(16 men and 20 women) aged from 17 to 49 years (mean
± SD 24.3 ± 7.6 years). Informed consent was obtained
from each subject, and the research followed the tenets of
the Declaration of Helsinki. The School of Life and Health
Sciences Human Ethics Committee at Aston University,
Birmingham, United Kingdom, approved all procedures.
IOP measurements were initially taken with the iCare
tonometer. For the purpose of this study, the iCare was
mounted onto a slit lamp base containing a bespoke align-
ment rig with six degrees of freedom, thus enabling pre-
cise and accurate manipulation of the probe position. The
micrometer scales used to modify the tonometer’s position
in relation to the cornea afforded a 0.01mm level of precision
for linear displacements and 1∘ for angular deviations (see
Figure 1). With the subjects seated, relaxed, and resting their
heads on the slit lamp, baseline IOP measurements were
acquired with the tip of the disposable iCare probe aligned
normal to the corneal apex and 5mm away from the anterior
corneal pole; this distance wasmeasured using the vertex dis-
tance scalemounted on anOculus Universal Spring Cell Trial
Frame (OCULUS Optikgera¨te GmbH, Mu¨nchholzha¨user,
Germany), whichwasworn for the entire duration of all iCare
measurements to enable continuous monitoring of the eye-
probe alignment.
To determine the effect of probe misalignments, IOP was
measured with the iCare tonometer in multiple positions.
Horizontal angular deviations included 5∘ nasally (5∘N), 10∘
nasally (10∘N), 5∘ temporally (5∘T), and 10∘ temporally (10∘T).
In addition, the iCare probe was deviated laterally by ±2mm
nasally (2N) and temporally (2T). The sequence of data
collection was randomised to control for the potential effect
of measurement order. For all positions, three repeats of six
consecutive readings were taken with the same iCare probe
and averaged.
On completion of all iCare IOP readings, GAT measure-
ments were taken. The GAT is currently the clinical gold
standard for measuring IOP [12] and has been described
in detail elsewhere [13]. Disposable Tonosafe probes were
used for all GAT readings, a protocol adopted in previous
investigations [5, 14], as repeated use of the original probe
Figure 1: Side view of the subject with the headrest and slit lamp
base to which the bespoke rig was attached and the iCare tonometer
fixed in place. The micrometer scale gauges used to modify the
tonometer’s position can be observed.
would otherwise require time-consuming sterilization proce-
dures, unsuitable for the present study. Following a slit lamp
examination of the anterior corneal surface, one drop of 0.5%
proxymetacaine and 0.25% fluorescein (Minims, Bausch &
Lomb Pharmaceuticals, Inc., FL, USA) was instilled into the
right eye of each subject.
A second UK-registered optometrist, who was blind to
the tonometer scale and to the iCare baseline readings, took
GATmeasures. All tonometry readings were acquired within
a 20-minute interval thus reducing the effect of diurnal
changes [15]. Again, a thorough slit lamp examination was
conducted following the procedure.
2.1. Statistical Analysis. All statistical analysis was carried
out using SigmaPlot (version 12; Systat Software UK Ltd.,
London, UK) and SPSS for Windows (version 15; SPSS Inc.,
Chicago, IL, USA). All data were assessed to confirm nor-
mality (using the Kolmogorov-Smirnov test). A probability
of <0.05 was taken as statistically significant. Differences in
IOPmeasurements with the two instruments were calculated
by subtracting the values obtained with the Goldmann
tonometer from those obtained with the iCare tonometer. In
addition, variations in iCare IOP values with probe deviation
in angle and position were calculated. Paired two-tailed 𝑡-
tests were used to determine any bias between the methods
[16]. Limits of agreement between measurements made with
GAT and iCare tonometer were expressed at the 95% level
(mean of the difference ± 1.96 SD of the differences) and
were also calculated as recommended by Bland and Altman
[17, 18].
3. Results
3.1. iCare Measurements at CC versus GAT. Themean IOP ±
SD, asmeasured byGAT, was 14.7 ± 2.5mmHg versus central
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Figure 2: Difference versus the mean plot illustrating the comparison between IOP measurements taken with GAT and iCare tonometer.
The iCare tonometer significantly overestimated IOP compared to the GAT. The solid line represents the mean bias, and the dashed lines
represent the 95% limits of agreement.
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Figure 3: Mean iCare IOP measurements at CC versus specified lateral and angular deviations. Deviating the ICare tonometer probe from
the optimal position had little effect on measurements, except at 10∘N, where the underestimate of IOP reached levels of significance. Error
bars represent ±1 SD.
iCare tonometer readings of 17.4 ± 3.6mmHg and represents
a significant positive correlation (𝑟 = 0.446; 𝑃 < 0.001) with
an overestimate of 2.7 ± 2.8mmHg (paired 𝑡-test: 𝑡 = 5.628,
𝑃 < 0.001) the bias of which increased at higher IOPs (see
Figure 2).
3.2. iCare Measurements at CC versus Specified Lateral
and Angular Deviations. Measures of IOP at CC using the
iCare tonometer were not significantly different to those
with lateral displacement of the probe at 2N (paired 𝑡-
test: 𝑡= 1.18, 𝑃 = 0.246) or at 2T (paired 𝑡-test: 𝑡 = 1.295,
𝑃 = 0.204). Comparisons were also made between the iCare
IOPmeasurements taken atCCand angular probe deviations;
these measures were statistically similar at 5∘T (paired 𝑡-
test: 𝑡 = 1.229, 𝑃 = 0.227), 10∘T (paired 𝑡-test: 𝑡 = 0.698,
𝑃 = 0.491), and 5∘N (paired 𝑡-test: 𝑡 = 1.280, 𝑃 =
0.209), but not at 10∘N (paired 𝑡-test: 𝑡 = 2.243, 𝑃 =
0.031), which showed an underestimation of IOP compared
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Figure 4: Difference versusmean plot illustrating the comparison between IOPmeasurements taken with the iCare tonometer at the baseline
position (CC) and at specified lateral deviations. (a) iCare tonometer probe was laterally displaced 2mmnasally from the centre of the cornea.
(b) iCare tonometer probe was laterally displaced 2mm temporally from the centre of the cornea. The solid line represents the mean bias,
and the dashed lines represent the 95% limits of agreement with the dotted regression line displayed. Lateral deviation of the probe showed
no significant correlation with measures at CC in nasal or temporal positions.
with central corneal apex measures of 0.8 ± 2.1mmHg
(see Figure 3).
Analysis showed no significant correlation between iCare
tonometer measures of IOP at CC and those taken at a lateral
deviation of 2mm nasally (𝑟 = 0.079, 𝑃 = 0.646) nor
when measured 2mm temporally (𝑟 = 0.171, 𝑃 = 0.319)
(see Figure 4). For angular deviations, analysis showed no
significant correlation between iCare tonometer measures of
IOP at CC and those taken at 5∘T (𝑟 = 0.289, 𝑃 = 0.088), 10∘T
(𝑟 = 0.047, 𝑃 = 0.785), 5N (𝑟 = 0.118, 𝑃 = 0.493), and 10∘N
(𝑟 = 0.103, 𝑃 = 0.549) (see Figure 5).
4. Discussion
The purpose of the present study was to determine the
effect of specified lateral and angular deviations of the iCare
tonometer probe on the accuracy of IOP measurement as
compared to readings in the optimal position, namely, the
central corneal apex; this is the first time that a study of this
type has used a bespoke rig to carefully control the desired
iCare tonometer probe positions. Further, the relatively small
lateral and angular deviations specified in the present study,
confined to the central 4mm zone, were chosen to assimilate
the typical misalignments that could occur in everyday
clinical practice. IOP measurements taken at the central
corneal apex were also compared to the current clinical gold
standard, the Goldmann applanation tonometer, in normal,
healthy subjects.
The present study has confirmed, in broad agreement
with earlier work [11, 19, 20], that in comparison to GAT,
the iCare tonometer overestimates IOP, with this bias widen-
ing at higher readings. That is to say, the iCare overestimates
IOP for patients with higher IOP values.
For lateral deviations, the iCare tonometer readings were
marginally lower than those at the central corneal apex (see
Figure 3) but not at levels of statistical significance either at
nasal or temporal eccentricities. Similarly, for angular devi-
ations of 5 and 10 degrees temporally, and 5 degrees nasally,
iCare tonometer readings were lower than readings with the
instrument in its optimal position, but not reaching levels of
statistical significance. However, when the iCare tonometer
probe was deviated 10 degrees nasally, the underestimate of
IOP did reach a significant level statistically, although this
<1mmHg difference is of little consequence in a clinical
context considering the intrasubject variability ofGoldmann-
type tonometers [21].
A principal advantage of the iCare rebound tonometer is
its ability to measure IOP in patients who are supine at the
time of examination. Although our device was able to control
accurately the position of the upright iCare tonometer, our
study did not examine the influence of patient position on the
resultant IOP value. A further study, therefore, is indicated
to examine the influence of probe position (upright versus
horizontal) on IOP readings in healthy and diseased eyes. In
this regard, it would also be interesting to examine patients
with corneal pathology (e.g., band keratopathy), which may,
Journal of Ophthalmology 5
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Figure 5: Difference versusmean plot illustrating the comparison between IOPmeasurements taken with the iCare tonometer at the baseline
position (CC) and at specified angular deviations. (a) iCare tonometer probe was displaced by an angle of 10 degrees nasally. (b) iCare
tonometer probe was displaced by an angle of 5 degrees nasally. (c) iCare tonometer probe was displaced by an angle of 5 degrees temporally.
(d) iCare tonometer probe was displaced by an angle of 10 degrees temporally. The solid line represents the mean bias, and the dashed
lines represent the 95% limits of agreement with the dotted regression line displayed. Angular deviation of the probe showed no significant
correlation with measures at CC, in either of the two nasal and temporal positions.
in turn, influence the resultant IOP value measured with the
iCare.
5. Conclusions
The present study has shown that the iCare tonometer is
clinically robust to small but tangible lateral and angular
deviations that can occur during the use of a handheld instru-
ment in general ophthalmic practice.
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